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Advanced thoracic endovascular aortic repair: Late
complications of thoracic endografts
Pegge Halandras, MD, and Ross Milner, MD, Maywood, IllThe endovascular treatment of aortic aneurysm disease
was first presented as an alternative to open repair by the
placement of an abdominal aortic endograft by Juan Parodi
in 1991.1 In the same year, Volodos et al2 published their
experience with endograft placement in the thoracic aorta.
Since this time, endovascular repair of descending thoracic
aortic aneurysms has emerged as an attractive treatment
modality. Several studies have confirmed the safety of tho-
racic endovascular aortic aneurysm repair (TEVAR) for
treatment of descending thoracic aortic aneurysms and
showed both lower rates of aneurysm-related deaths and
major adverse events compared with open aneurysm re-
pair.3,4
The enthusiasm for endovascular treatment of thoracic
aneurysmal disease has resulted in the expansion of endo-
vascular treatment of nonaneurysmal thoracic pathology.
Acceptance of endovascular treatment of thoracic aortic
pathology has presented new challenges in the develop-
ment of long-term complications associated with the
unique environment of the thoracic aorta and thoracic
aortic endograft designs. Many of the late complications
seen with TEVAR stem directly from the evolution of stent
design, the unique challenges posed by the proximal and
distal landing zones, and the hemodynamic forces encoun-
tered in the thoracic aorta.
DEVICE COLLAPSE
The thoracic aorta provides a hostile environment for
thoracic stent graft placement because of high flow pulsa-
tion and acute aortic angulation. The W.L. Gore manufac-
turer’s 2008 Annual Clinical Update confirmed compres-
sion of Gore TAG devices is a rare event, with 95 device
compressions of approximately 25,000 implanted devices
reported worldwide. Proximal endograft compressionmost
commonly occurs in the setting of excessive oversizing and
the presence of an acute angle at the junction of the distal
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100Saortic arch and descending thoracic aorta. In this environ-
ment, inadequate apposition of the stent to the aortic arch
curvature and high pulsatility of aortic blood flow may
result in compression in the unopposed endograft edge.
Graft infolding or pleating noted at the time of initial
endograft placement has also been attributed to endograft
collapse. Infolding or pleating is most often associated with
oversizing.
Secondary endovascular interventions to treat com-
pression should be focused on re-expanding the initial stent
graft, providing additional radial force, and achieving ade-
quate aortic wall apposition. Re-expansion can be achieved
with deployment of an additional endograft or bare-metal
balloon-expandable stent within the collapsed portion of
the initial endograft.5,6
COMPONENT SEPARATION
The thoracic aorta is relatively mobile, with fixation
points limited to origin of the arch branch vessels and celiac
artery. This mobility in combination with the acute angle at
the junction of the distal aortic arch and descending tho-
racic aorta and remodeling of the aorta after TEVAR cre-
ates an opportunity for potential endograft component
separation and type III endoleaks (Fig 1). The late appear-
ance of a type III endoleak may be secondary to device
Fig 1. Left, A computed tomography angiography demonstrates
contrast extravasation from a type III endoleak into the residual
aneurysm sac (arrow). Right, The computed tomography recon-
struction confirms a type III endoleak has occurred at the junction
between two overlapping thoracic endografts (arrow).migration, and precautions to prevent this complication at
ed fo
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tween devices of 5 cm.
Identification of component separation requires ag-
gressive postoperative surveillance and can be treated by
covering the junctional defect with a stent graft extension.
Failure to resolve type III endoleaks leaves the patient
unprotected from aneurysm rupture and may ultimately
require conversion to open treatment of a thoracic aneu-
rysm.
DEVICE COMPLICATIONS
Fractures. Long-term success with thoracic endograft
placement requires a device design that can maintain stent
integrity and withstand changes created by aortic remodel-
ing. Metal fracture is a result of metal fatigue created by the
circumferential, radial, and torsional stresses endografts are
subjected to by repetitive aortic pulsation (Fig 2). Just as
abdominal aortic endografts have progressively improved,
thoracic endograft technology continues to evolve. Results
of the phase II multicenter trial of the GORETAG thoracic
endoprosthesis identified 20 stent fractures in 19 patients at
2 years. Of the 20 fractures, 18 were associated with the
longitudinal spine of an axial wire used for deployment.
Fig 2. Left, Metal fractures are shown associated with
modifications of the new-generation TAG device approv
Fig 3. Left, The bare spring configuration of early-st
leading end of a proximal bare spring is shown.This complication resulted in a voluntary recall of thisdevice. The new generation of the Excluder device has been
modified with exclusion of this axial wire.4
Fabric erosion and suture breakage. The other po-
tential forms of device fatigue that complicate endograft
placement are fabric erosion and suture breakage. Graft
material fatigue is a rare event that has been reported in
both polyester grafts and expanded polytetrafluoroeth-
ylene grafts.7 In addition, many devices use polypro-
pylene sutures to fix grafts to the metal frame, which
results in the potential risk of suture breakage.
A recent analysis of a large series of 618 patients
treated with various types of both abdominal and tho-
racic endografts identified 60 patients with mechanical
failure of implanted stents. Surveillance revealed 43 pa-
tients with metallic stent fractures, 14 patients with
suture disruptions, and 3 patients with graft wear. Suture
disruptions and fabric fatigue were attributed to micro-
motion of individual stents, possible increased residual
aneurysm sac pressure in the setting of endoleaks, and
theoretic complications of graft manufacturing and
packaging. Six patients in that series required surgical
conversion and the remaining patients did not sustain
h longitudinal spines and nitinol rings. Right, Device
r use in the United States are highlighted.
evices is depicted. Right, Aortic perforation from thebotage dadverse events. The clinical significance of stent graft
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AORTIC WALL PERFORATION
Early devices were developed to achieve proximal and
distal fixation with bare spring designs. This design specifi-
cation has proven to be problematic, because perforation of
the aortic wall has been reported in association with the
apex of the proximal springs. Owing to the acute angle
created by the aortic arch and descending thoracic aorta,
devices landed in this proximal region are subject to the
forces of aortic pulsation. Over time, this creates an envi-
ronment resulting in erosion of the apex of the bare spring
through the aortic wall (Fig 3).9 Along with new stent
designs such as those without bare-metal springs or those
with covered flared ends, placement of stents in the hori-
zontal portion of the aortic arch can help eliminate this
complication. This may necessitate coverage of the left
subclavian artery or aortic arch debranching procedures.
Perforations at distal fixation sites have also been re-
ported. Distal perforations occur in association with place-
ment of distal bare-metal springs in an area of acute aortic
angulation. To decrease the risk of perforation, placement
of more than one endograft may be required. This tech-
nique will create overlap and, hopefully, disperse stress
associated with this angulation.
CONCLUSIONS
The less invasive nature and successful use of thoracic
endografts has contributed to the rapid advancement of
this technology. The tortuous aortic landing zones and
hostile environment created by continual aortic pulsation
and aortic remodeling contributes to the development of
late complications. Many of these late complications have
been minimized by the development of improved thoracic
endograft designs. In addition, most late complications can
be repaired with secondary endovascular interventions if
recognized with diligent postoperative surveillance. De-
spite these advances, long-term data regarding TEVAR are
lacking and will likely result in the development of addi-
tional types of late complications.AUTHOR CONTRIBUTIONS
Conception and design: PH
Analysis and interpretation: PH
Data collection: Not applicable
Writing the article: PH
Critical revision of the article: RM
Final approval of the article: RM
Statistical analysis: Not applicable
Obtained funding: Not applicable
Overall responsibility: RM
REFERENCES
1. Parodi JC, Palmaz JC, Barone HD. Transfemoral intraluminal graft
implantation for abdominal aortic aneurysms. Ann Vasc Surg 1991;5:
491-9.
2. Volodos NL, Karpovich IP, Troyan VI, Kalashnikova YuV, Shekhanin
VE, Ternyuk NE, et al. Clinical experience of the use of self-fixing
synthetic prostheses for remote endoprosthetics of the thoracic and the
abdominal aorta and iliac arteries through the femoral artery and as
intraoperative endoprosthesis for aorta reconstruction. Vasa Suppl 1991;
33:93-5.
3. Makaroun MS, Dillavou ED, Wheatley GH, Campbria RP. Five-year
results of endovascular treatment with the Gore TAG device compared with
open repair of thoracic aortic aneurysms J Vasc Surg 2008;47:912-8.
4. Makaroun MS, Dillavou ED, Kee ST, Sicard G, Chaikof E, Bavaria J, et
al. Endovascular treatment of thoracic aortic aneurysms: results of the
phase II multicenter trial of the GORE TAG thoracic endoprosthesis. J
Vasc Surg 2005;41:1-9.
5. Rodd CD, Desigan S, Hamady MS, Gibbs RG, Jenkins MP. Salvage
options after stent collapse in the thoracic aorta. J Vasc Surg 2007;46:
780-5.
6. Steinbauer MG, Stehr A, Pfister K, Herold T, Zorger N, Tope I, et al.
Endovascular repair of proximal endograft collapse after treatment for
thoracic aortic disease. J Vasc Surg 2006;43:609-12.
7. Riepe G, Loos J, Imig H, Schroder A, Schneider E, Petermann J, et al.
Long-term in vivo alterations of polyester vascular grafts in humans. Eur
J Endovasc Surg 1997;13:540-8.
8. Jacobs TS, Won J, Gravereaux EC, Faries PL, Morrissey N, Teodorescu
VJ, et al. Mechanical failure of prosthetic human implants: a 10-year
experience with aortic stent graft devices. J Vasc Surg 2003;37:16-26.
9. Fattori R, Lovato L, Buttazzi K, Di Bartolomeo R, Gavelli G. Extension
of dissection in stent graft treatment of type B aortic dissection: lessons
learned from endovascular experience. J Endovasc Ther 2005;12:306-11.Submitted Jun 15, 2010; accepted Jun 17, 2010.
